Cargando…

Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years

Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials and nanotechnology have attracted more attention and greatly improved the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Xinyan, Wu, Junyong, Xiang, DaXiong, Yang, Yongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896221/
https://www.ncbi.nlm.nih.gov/pubmed/35250598
http://dx.doi.org/10.3389/fphar.2022.846715
_version_ 1784663113068445696
author Hao, Xinyan
Wu, Junyong
Xiang, DaXiong
Yang, Yongyu
author_facet Hao, Xinyan
Wu, Junyong
Xiang, DaXiong
Yang, Yongyu
author_sort Hao, Xinyan
collection PubMed
description Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials and nanotechnology have attracted more attention and greatly improved the efficiency of tumor therapies and significantly prolonged the survival period, whether for traditional tumor treatment methods such as radiotherapy, or emerging methods, such as phototherapy and immunotherapy, sonodynamic therapy, chemodynamic therapy and RNA interference therapeutics. Various monotherapies have obtained positive results, while combination therapies are further proposed to prevent incomplete eradication and recurrence of tumors, strengthen tumor killing efficacy with minimal side effects. In view of the complementary promotion effects between different therapies, it is vital to utilize nanomaterials as the link between monotherapies to achieve synergistic performance. Further development of nanomaterials with efficient tumor-killing effect and better biosafety is more in line with the needs of clinical treatment. In a word, the development of nanomaterials provides a promising way for tumor treatment, and here we will review the emerging nanomaterials towards radiotherapy, phototherapy and immunotherapy, and summarized the developed nanocarriers applied for the tumor combination therapies in the past 5 years, besides, the advances of some other novel therapies such as sonodynamic therapy, chemodynamic therapy, and RNA interference therapeutics have also been mentioned.
format Online
Article
Text
id pubmed-8896221
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88962212022-03-05 Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years Hao, Xinyan Wu, Junyong Xiang, DaXiong Yang, Yongyu Front Pharmacol Pharmacology Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials and nanotechnology have attracted more attention and greatly improved the efficiency of tumor therapies and significantly prolonged the survival period, whether for traditional tumor treatment methods such as radiotherapy, or emerging methods, such as phototherapy and immunotherapy, sonodynamic therapy, chemodynamic therapy and RNA interference therapeutics. Various monotherapies have obtained positive results, while combination therapies are further proposed to prevent incomplete eradication and recurrence of tumors, strengthen tumor killing efficacy with minimal side effects. In view of the complementary promotion effects between different therapies, it is vital to utilize nanomaterials as the link between monotherapies to achieve synergistic performance. Further development of nanomaterials with efficient tumor-killing effect and better biosafety is more in line with the needs of clinical treatment. In a word, the development of nanomaterials provides a promising way for tumor treatment, and here we will review the emerging nanomaterials towards radiotherapy, phototherapy and immunotherapy, and summarized the developed nanocarriers applied for the tumor combination therapies in the past 5 years, besides, the advances of some other novel therapies such as sonodynamic therapy, chemodynamic therapy, and RNA interference therapeutics have also been mentioned. Frontiers Media S.A. 2022-02-18 /pmc/articles/PMC8896221/ /pubmed/35250598 http://dx.doi.org/10.3389/fphar.2022.846715 Text en Copyright © 2022 Hao, Wu, Xiang and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Hao, Xinyan
Wu, Junyong
Xiang, DaXiong
Yang, Yongyu
Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
title Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
title_full Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
title_fullStr Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
title_full_unstemmed Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
title_short Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
title_sort recent advance of nanomaterial-mediated tumor therapies in the past five years
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896221/
https://www.ncbi.nlm.nih.gov/pubmed/35250598
http://dx.doi.org/10.3389/fphar.2022.846715
work_keys_str_mv AT haoxinyan recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears
AT wujunyong recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears
AT xiangdaxiong recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears
AT yangyongyu recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears